1.20

8.11% 0.09

After Hours: 1.16 -0.04 -3.33%

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $1.20, with a volume of 72,543. It is up +8.11% in the last 24 hours and down -39.39% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Previous Close:

$1.11

Open:

$1.15

24h Volume:

72,543

Relative Volume:

0.78

Market Cap:

$3.24M

Revenue:

$832.80K

Net Income/Loss:

$-21.55M

P/E Ratio:

-0.0996

EPS:

-12.0465

Net Cash Flow:

$-12.71M

1W Performance:

+5.82%

1M Performance:

-39.39%

6M Performance:

-70.44%

1Y Performance:

-92.59%

1-Day Range:

$1.15

$1.29

1-Week Range:

$0.9532

$1.29

52-Week Range:

$0.9532

$41.20

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1115)

Industry

Biotechnology (624)

Phone

954-842-2024

Address

2929 N COMMERCE PKWY, MIRAMAR

Employee

Twitter

Next Earnings Date

2025-04-01

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB Hcw Biologics Inc	1.20	3.00M	832.80K	-21.55M	-12.71M	-12.05
VRTX Vertex Pharmaceuticals Inc	468.38	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.54	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	406.40	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	803.74	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.07	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Hcw Biologics Inc Stock (HCWB) Latest News

Dec 31, 2025

HCW Biologics reports steps to regain Nasdaq compliance following equity transactions - Investing.com

Dec 31, 2025

HCW Biologics reports steps to regain Nasdaq compliance following equity transactions By Investing.com - Investing.com South Africa

Dec 31, 2025

HCW Biologics Restructures Obligations to Regain Nasdaq Compliance - TipRanks

Dec 31, 2025

HCW Biologics Achieves Nasdaq Compliance Milestone - TradingView — Track All Markets

Dec 31, 2025

Dec 30, 2025

Returns Recap: Will HCW Biologics Inc stock attract ESG investorsEarnings Beat & Daily Price Action Insights - moha.gov.vn

Dec 30, 2025

HCW Biologics Granted Nasdaq Compliance Extension - MSN

Dec 30, 2025

Dec 25, 2025

US Market Recap: How analysts rate HCW Biologics Inc stock todayWeekly Investment Summary & Precise Buy Zone Identification - moha.gov.vn

Dec 25, 2025

Dec 24, 2025

HCW Biologics (NASDAQ:HCWB) Shares Down 0.2% – Time to Sell? - Defense World

Dec 24, 2025

Dec 23, 2025

Reviewing HCW Biologics (NASDAQ:HCWB) and ImmunityBio (NASDAQ:IBRX) - Defense World

Dec 23, 2025

Dec 22, 2025

HCW Biologics Earnings Notes - Trefis

Dec 22, 2025

Dec 20, 2025

Is HCW Biologics Inc. stock gaining market shareJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда

Dec 20, 2025

Dec 19, 2025

Is HCW Biologics Inc. stock attractive for growth ETFsMarket Performance Report & Low Drawdown Investment Ideas - Улправда

Dec 19, 2025

Is HCW Biologics Inc. stock a buy in volatile markets2025 Price Targets & Long Hold Capital Preservation Plans - Улправда

Dec 19, 2025

How analysts rate HCW Biologics Inc. stock todayJuly 2025 Snapshot & Weekly High Return Stock Forecasts - Bölüm Sonu Canavarı

Dec 19, 2025

Is HCW Biologics Inc. stock recession proofEarnings Trend Report & Real-Time Chart Breakout Alerts - DonanımHaber

Dec 19, 2025

Can HCW Biologics Inc. stock deliver consistent earnings growthMarket Activity Summary & AI Forecasted Entry/Exit Points - DonanımHaber

Dec 19, 2025

Can HCW Biologics Inc. stock deliver strong Q4 earningsMarket Activity Report & Community Trade Idea Sharing - bolumsonucanavari.com

Dec 19, 2025

Dec 07, 2025

HCW Biologics Inc Stock Analysis and ForecastREITs Market Trends & Investment Timing Techniques - earlytimes.in

Dec 07, 2025

Dec 04, 2025

Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser

Dec 04, 2025

Dec 03, 2025

Is HCW Biologics Inc. overvalued or undervalued? - Markets Mojo

Dec 03, 2025

Dec 02, 2025

HCW Biologics Amends License Agreement with Trimmune - MSN

Dec 02, 2025

How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser

Dec 02, 2025

HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World

Dec 02, 2025

Dec 01, 2025

HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 28, 2025

Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Form 8-KCurrent report - ADVFN

Nov 27, 2025

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Nov 27, 2025

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN

Nov 27, 2025

Nov 23, 2025